Key Viral Hepatitis Studies From AASLD 2021

November 12-15, 2021; Virtual
Read expert faculty members’ summaries of HBV, HCV, and hepatitis delta virus (HDV), including data on HBV therapy during pregnancy, outcomes following treatment withdrawal in HBV, progress toward an HBV cure, HDV clinical impact and phase III clinical trial updates, and HCV implementation science and current status of the cascade of care.
Nancy Reau, MD
Stefan Zeuzem, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 323 KB
Released: November 29, 2021

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
AbbVie
Gilead Sciences, Inc.

Related Content

Patient perspectives and key action items to address in clinical settings to reduce HBV care barriers in the United States, from Clinical Care Options (CCO)

Mindie H. Nguyen, MD, MAS, AGAF, FAASLD Jennifer Wild, MS, BSN, RN, OCN Released: June 22, 2022

Clinical Care Options (CCO) commentary from Dr Carla Coffin on risks vs benefits of treating patients in the indeterminate category for HBV treatment

person default Carla Coffin, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: June 21, 2022 Expired: June 20, 2023

Dr Norah Terrault: missed opportunities for hepatitis delta virus (HDV) testing and how to overcome them, from Clinical Care Options (CCO)

Norah Terrault Headshot Norah Terrault, MD, MPH Released: May 18, 2022

Clinical Care Options (CCO) commentary with advice for healthcare professionals from a person who had end-stage liver failure from a missed HCV diagnosis

person default Sherry Tierney Physicians: maximum of 0.5 AMA PRA Category 1 Credits Registered Nurses: 0.5 Nursing contact hours Pharmacists: 0.5 contact hours (0.05 CEUs) Released: May 17, 2022 Expired: May 16, 2023

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings